ArticleOphthalmology science
Enhanced Macular Telangiectasia Type 2 Detection: Leveraging Self-Supervised Learning and Ensemble Models.
Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Table-based language models for ophthalmology assessment in the emergency department.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026Article
- Machine learning for classification of periodontal defects (vertical versus horizontal) using CBCT datasets.Bioinformation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate an ensemble-based approach utilizing deep learning models for accurate and interpretable detection of macular telangiectasia (MacTel) type 2 on OCT imaging. Design: Retrospective analysis of OCT scans, model development, and assessment. Participants: A total of 5200 OCT images from participants in the MacTel Registry conducted by the Lowy Medical Research Institute and from the University of Washington (780 MacTel patients and 1900 non-MacTel patients). Methods Intervention or Testing: We trained multiple individual MacTel vs. non-MacTel classification models using traditional supervised learning and self-supervised learning (SSL) and ensembled them using average weighting methods. We investigated diverse methodologies for constructing the ensemble, including varied architectural configurations and learning paradigms of individual models, and manipulating the amount of labeled data accessible for training. Model performance was compared against human expert graders on held-out test set data. Model interpretability was investigated using gradient-weighted class activation maps (Grad-CAM) visualization and by evaluating interrater agreement. Main Outcome Measures: For model performance, area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, sensitivity, and specificity were reported. For interpretability, interrater agreements and Grad-CAM visualization results were evaluated. Results: Despite access to only 419 OCT volumes, including 185 MacTel patients within the 10% labeled training dataset, the ensemble model demonstrated a performance level (AUROC 0.972 [95% confidence interval (CI), 0.971-0.973], AUPRC 0.967 [95% CI, 0.965-0.969], accuracy 91.7%, sensitivity 0.905, and specificity 0.925) comparable to the human experts ensemble (AUROC 0.977 [95% CI, 0.975-0.978], AUPRC 0.987 [95% CI, 0.986-0.987], accuracy 96.8%, sensitivity 0.929, and specificity 1) on a test set of 500 patients. The individual models did not achieve the same performance levels when evaluated separately. Conclusions: Even with limited data, combining SSL with ensemble approaches improved MacTel classification accuracy and interpretation compared to the individual models. Self-supervised learning captures meaningful representations from unlabeled data, a key benefit in the setting of limited data such as with rare diseases. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.